GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain
Science Advances · 02.02.2024 · 10 (5)
DOI: 10.1126/sciadv.adj3808 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 02.02.2024. Verfasst von Hu-Hu Bai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, School of Pharmacy, Lanzhou University, Lanzhou, Gansu 730000, P.R. China. Hauptthemen laut MEDLINE: Pain, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
G protein–coupled receptor 39 (GPR39) senses the change of extracellular divalent zinc ion and signals through multiple G proteins to a broad spectrum of downstream effectors. Here, we found that GPR39 was prevalent at inhibitory synapses of spinal cord somatostatin-positive (SOM + ) interneurons, a mechanosensitive subpopulation that is critical for the conveyance of mechanical pain. GPR39 complexed specifically with inhibitory glycine receptors (GlyRs) and helped maintain glycinergic transmission in a manner independent of G protein signalings. Targeted knockdown of GPR39 in SOM + interneurons reduced the glycinergic inhibition and facilitated the excitatory output from SOM + interneurons to spinoparabrachial neurons that engaged superspinal neural circuits encoding both the sensory discriminative and affective motivational domains of pain experience. Our data showed that pharmacological activation of GPR39 or augmenting GPR39 interaction with GlyRs at the spinal level effectively alleviated the sensory and affective pain induced by complete Freund’s adjuvant and implicated GPR39 as a promising therapeutic target for the treatment of inflammatory mechanical pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology, School of Pharmacy, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
- School of Life Science, Lanzhou University, Lanzhou, Gansu 730000, P.R. China.
- School of Public Health, Gansu University of Chinese medicine, Lanzhou, Gansu 730000, P.R. China.
ORCID-Profile: Hu-Hu Bai, Xiao-Dong Hu
Zitieren
APA
Bai, H. H., Wang, K. L., Zeng, X. R., Li, J., Li, Y., Xu, J. Y., Zhang, Y., Jiang, H. F., Yang, X., Suo, Z. W., & Hu, X. D. (2024). GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain. Science Advances, 10(5). https://doi.org/10.1126/sciadv.adj3808
Vancouver
Bai HH, Wang KL, Zeng XR, Li J, Li Y, Xu JY, et al. GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain. Science Advances. 2024;10(5). doi:10.1126/sciadv.adj3808
BibTeX
@article{Bai2024,
author = {Bai, Hu-Hu and Wang, Kang-Li and Zeng, Xiang-Ru and Li, Jing and Li, Yuan and Xu, Jia-Yu and Zhang, Yue and Jiang, Hai-Feng and Yang, Xian and Suo, Zhan-Wei and Hu, Xiao-Dong},
title = {GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {5},
doi = {10.1126/sciadv.adj3808}
}
EUVIMED